Status:
COMPLETED
Using Cranial Nerve Non-invasive Neuromodulation to Improve Pain and Upper Extremity Function After a Stroke
Lead Sponsor:
Université de Sherbrooke
Conditions:
Stroke
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Following a stroke, individuals experience pain in the affected upper limb (UL) and residual weakness in the UL, which impacts their quality of life and performance of activities of daily living. To o...
Detailed Description
Following a stroke, survivors experience pain in the affected upper limb (UL) and residual weakness in the UL, which impacts their quality of life and performance of activities of daily living. Exerci...
Eligibility Criteria
Inclusion
- Be ≥18 years old;
- Have had a single supratentorial stroke;
- Be in a chronic stroke phase (\>6 months);
- Present motor recovery in the upper limb (UL) (Fugl-Meyer Stroke Assessment \[FMA\] score ≥20/66);
- Have completed any rehabilitation treatment.
Exclusion
- A significant spasticity at the affected upper limb (score \> 3 on the modified Ashworth scale);
- A major sensory deficit at the affected upper limb (a score ≤25/34 on the Nottingham Sensory Assessment and a score \<6 on the evaluation of the vibration threshold);
- A presence of hemineglect (score ≥±0. 083 on the Line Cancellation test);
- An apraxia (score \>2.5 on the Alexander Test);
- The presence of a neurological disorder other than a stroke;
- Concomitant orthopaedic problem at the affected UL;
- Cognitive impairment (Mini-Cog score \<2/5) and
- Any contraindication to CN-NINM.
Key Trial Info
Start Date :
June 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05370274
Start Date
June 27 2022
End Date
June 21 2023
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche sur le vieillissement
Sherbrooke, Quebec, Canada, J1H4C4